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Objectives
To determine whether a needle disinfectant step during
transrectal ultrasonography (TRUS)-guided prostate biopsy is
associated with lower rates of infection-related hospitalisation.
Patients and Methods
We conducted a retrospective analysis of all TRUS-guided
prostate biopsies taken across the Michigan Urological Surgery
Improvement Collaborative (MUSIC) from January 2012 to
March 2015. Natural variation in technique allowed us to
evaluate for differences in infection-related hospitalisations
based on whether or not a needle disinfectant technique was
used. The disinfectant technique was an intra-procedural step
to cleanse the biopsy needle with antibacterial solution after
each core was sampled (i.e., 10% formalin or 70% isopropyl
alcohol). After grouping biopsies according to whether or not
the procedure included a needle disinfectant step, we compared
the rate of infection-related hospitalisations within 30 days of
biopsy. Generalised estimating equation models were fit to
adjust for potential confounders.
Results
During the evaluated period, 17 954 TRUS-guided
prostate biopsies were taken with 5 321 (29.6%) including
a disinfectant step. The observed rate of infection-related
hospitalisation was lower when a disinfectant
technique was used during biopsy (0.60% vs 0.90%;
P = 0.04). After accounting for differences between groups
the adjusted hospitalisation rate in the disinfectant group
was 0.85% vs 1.12% in the no disinfectant group
(adjusted odds ratio 0.76, 95% confidence interval
0.50–1.15; P = 0.19).
Conclusions
In this observational analysis, hospitalisations for infectious
complications were less common when the TRUS-guided
prostate biopsy included a needle disinfection step. However,
after adjusting for potential confounders the effect of needle
disinfection was not statistically significant. Prospective
evaluation is warranted to determine if this step provides a
scalable and effective method to minimise infectious
complications.
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Introduction
Infectious complications from transrectal prostate biopsies are
estimated to occur after 5–7% of biopsies and can lead to
significant morbidity and substantial cost [1]. Although less
common, more severe infections requiring hospitalisation
occur after 1–3% of biopsies and are associated with even
greater human and financial costs [1]. Fluoroquinolone
resistance has been shown to be a contributing factor to these
infections and modifications to prophylactic pathways
including rectal culture-directed antibiotics and addition of
non-fluoroquinolone augmented prophylactic regimens have
led to decreases in infectious complications [2–4]. These
strategies represent important quality initiatives that have
improved patient care. However, implementation challenges,
risks of further resistance, and antibiotic side-effects may
leave room for even greater improvement [1].
An ideal quality improvement strategy to reduce prostate
biopsy related infections would be effective, inexpensive, easy
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to implement, and safe, whilst not augmenting antibiotic
resistance. Non-antibiotic strategies of varied effectiveness,
such as rectal preparation and transperineal biopsy, have
previously been investigated but have not been widely
adopted [5,6]. More recently, the role of intra-procedural
needle disinfection using 10% formalin during prostate biopsy
was evaluated as a means to potentially reduce intra-prostatic
bacterial inoculation and thus diminish the risks of UTI and/
or sepsis after biopsy [7]. That single-centre study did not
show a statistically significant benefit to needle disinfection;
however, the simplicity of this intervention is compelling and
warrants further investigation.
In this context, we evaluated the impact of an intra-
procedural needle disinfectant step on the rate of infection-
related hospitalisation within 30 days of TRUS-guided
prostate biopsy for patients managed in the diverse academic
and community practices comprising the Michigan Urological
Surgery Improvement Collaborative (MUSIC). Understanding
whether addition of intra-procedural needle disinfection to
TRUS-guided prostate biopsy reduces infection-related
complications will help urologists working to optimise the
safety of prostate biopsy.
Patients and Methods
Data Source
MUSIC was established in 2011 in partnership with Blue
Cross Blue Shield of Michigan. The quality improvement
collaborative currently comprises 43 urology practices with
>240 urologists, which represents nearly 90% of the urologists
in the State. For all prostate biopsies taken across the
collaborative, trained data abstractors review all clinical
documentation related to a prostate biopsy and follow-up,
and prospectively enter into a web-based clinical registry a
standardised set of demographic and clinicopathological data
pertaining to biopsy findings and complications occurring
within 30 days. Prior reports have described the MUSIC’s
data quality control activities, including annual data audits at
each practice and validation analyses based on insurance
claims [4,8]. Each MUSIC practice obtained an exemption or
approval for collaborative participation from a local
Institutional Review Board.
Patients and Comparison Groups
The cohort for this analysis included all TRUS-guided
prostate biopsies taken in participating MUSIC practices from
January 2012 to March 2015. During the period evaluated,
natural variation across providers and practices determined
whether a disinfectant step was used or not during a given
procedure. After the MUSIC Coordinating Centre verified
each urologist’s technique, biopsies were grouped according
to whether or not a disinfectant technique was used.
Needle Disinfectant Techniques
Urologists that used a needle disinfectant technique used one
of two strategies for needle disinfection referred to hereafter
as the ‘formalin technique’ or the ‘alcohol technique’. In the
formalin technique, after each core is taken, with a standard
spring-loaded biopsy needle, the external sheath is withdrawn
to expose the core. The needle is then submerged in a sterile
specimen cup containing 10% formalin and swirled to
dislodge the core and bathe the needle in the disinfectant
solution (Fig. 1). Some urologists rinsed the needle in a cup
of sterile saline before using it to obtain the next specimen.
The alcohol technique involves 70% isopropyl alcohol as the
disinfectant solution, which is used to soak a Telfa sponge
(American Surgical Company, Salem, MA, USA). After each
core is obtained the external sheath is drawn back to expose
the core, the needle is wiped on the alcohol soaked sponge to
dislodge the core and also disinfect the needle tip (Fig. 2).
Outcome
The primary outcome measure compared across groups was
the rate of hospital admission within 30 days of biopsy for a
primary diagnosis of UTI, fever, or sepsis.
Statistical Analyses
We performed univariate comparisons of demographic and
baseline clinical information for the disinfectant vs no
disinfectant groups. Student’s t-tests were used to compare
continuous measures, whilst chi-squared tests were used for
categorical outcomes. After comparing the rate of
hospitalisation across groups, we used common statistical
methods [9,10] to fit a generalised estimating equation (GEE)
model with logit link to assess the independent association
Fig. 1 Demonstration of the formalin disinfectant technique.
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between use of a disinfectant technique and post-biopsy
infection-related hospitalisation. The model adjusted for
patient age, presence of diabetes, history of prior biopsy, and
whether a biopsy occurred before or after our State-wide
intervention aimed at addressing fluoroquinolone resistance
with either culture-directed or augmented antibiotic
prophylaxis [4]. The model accounted for within-patient
correlation for patients with more than one biopsy in the
dataset.
Two sub-group analyses were performed. In the first sub-
group analysis, we fitted a separate GEE model to a sub-
cohort of biopsies where more information about other
infectious risk factors was available. At the time of these
procedures, a questionnaire was completed detailing whether
a patient received antibiotics in the 6 months before biopsy,
had travelled internationally in the past 6 months, or was
taking immunosuppressive medications. Each of these factors
was added as a dichotomous co-variate in a GEE model that
also included all co-variates for the base model used in the
primary analysis, and we again evaluated for an independent
relationship between the disinfectant technique and infection-
related hospitalisation after adjusting for these other factors.
In a second sub-group analysis, the observed rate of
infection-related hospitalisation was compared across study
groups for the subsets of biopsies taken before and after the
aforementioned State-wide antibiotic intervention that has
significantly reduced infection rates across the MUSIC [4]. All
statistical testing was performed using commercially available
software [Statistical Analysis System (SAS) version 9.4; SAS
Institute, Cary, NC, USA] at the 5% significance level.
Results
Across 41 practices and 233 urologists, 16 920 patients
underwent 17 954 TRUS-guided biopsies during the study
period. Most of the biopsies were taken without a disinfectant
technique (12 633, 70.4%). Amongst the biopsies taken with a
disinfectant technique, the formalin technique was used in 4
870/5 321 (91.5%), with the alcohol technique used in the
remaining 451 (8.5%) biopsies.
Demographic information for the study groups is reported in
Table 1. The mean age was similar, at 64.1 vs 64.4 years
(P = 0.08), in the no disinfectant and disinfectant groups,
respectively. Men in the needle disinfectant group were less
likely to have received a prior biopsy (Table 1). Relative to
biopsies taken without a disinfectant technique, a greater
proportion of the biopsies using a disinfectant technique were
taken after the collaborative-wide effort to reduce biopsy-
related infections with use of either culture-directed or
augmented antibiotic prophylaxis (87.6% vs 63.3%;
P < 0.001).
Infection-related hospitalisations were less common after
biopsies that included a needle disinfectant technique, with 32
admissions (0.60%) vs 114 admissions (0.90%) for biopsies no
disinfectant step [odds ratio (OR) 0.67; P = 0.040] (Fig. 3a).
There were no admissions reported for the 451 biopsies taken
Fig. 2 Demonstration of the alcohol disinfectant technique. Needle is
wiped against a Telfa sponge soaked in 70% isopropyl alcohol to dislodge
sampled prostate core.
Table 1 The characteristics of patients undergoing TRUS-guided prostate biopsy with or without a needle disinfectant technique.
Variable No disinfectant Disinfectant P*
Number of patients 12 633 5 321 –
Age, years, mean (SD) 64.1 (8.4) 64.4 (8.3) 0.08
Patients with diabetes, n (%) 1 794 (14.2) 771 (14.5) 0.99
History of prior biopsy, n (%) 3 240 (25.9) 1 261 (23.9) 0.004
Number of cores sampled, mean (SD) 12.4 (3.3) 12.4 (3.8) 0.23
Biopsy occurrence after the MUSIC antibiotic intervention, n (%) 7 995 (63.3) 4 660 (87.6) <0.001
*Student’s t-test used to compare continuous measures and chi-squared test for categorical measures.
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using 70% isopropyl alcohol as a disinfectant. There were no
deaths in either group, or any reported adverse events related
to the use of needle disinfectant.
Table 2 reports findings from our multivariable analyses. Men
with diabetes and those undergoing biopsy prior to the
MUSIC’s antibiotic intervention were more likely to be
hospitalised for an infection after biopsy. After adjusting for
the covariates in Table 2, there was no longer a statistically
significant difference in hospitalisation rates across study
groups (adjusted OR 0.76, 95% CI: 0.50–1.15; P = 0.19;
Fig. 3B).
In the first sub-group analysis there were 8 382 biopsies
included. After adjusting for the factors included in the
primary analysis, as well as for use of antibiotics during the
6 months before biopsy, recent international travel, and
whether a patient was taking immunosuppressants at the time
of biopsy, there was not a statistically significant difference in
hospitalisation rates attributable to use of a needle
disinfectant technique (adjusted OR 0.86, 95% CI: 0.47–1.58;
P = 0.64, reference = no use of disinfectant). None of the
added risk factors was a significant predictor of
hospitalisation in this sub-cohort, with the following adjusted
ORs for hospitalisation: (i) using antibiotics in 6 months
before biopsy (adjusted OR 1.20, 95% CI: 0.67–2.17;
P = 0.54), (ii) recent international travel (adjusted OR 1.72,
95% CI: 0.81–3.67; P = 0.16), and (iii) use of
immunosuppressants at time of biopsy (adjusted OR 1.77,
95% CI: 0.55–5.71; P = 0.33).
A second sub-group analysis of the 5 299 biopsies taken
before the MUSIC antibiotic intervention showed no
significant difference in hospitalisation rates when 661
disinfectant biopsies (five hospitalisations, rate 0.76%) were
compared to 4 638 taken without disinfectant (56
hospitalisations, rate 1.21%; P = 0.31; Fig. 4). Similarly, there
was no difference in rate of infection-related hospitalisation
when comparing 4 660 disinfectant biopsies (27
hospitalisations, rate 0.58%) to 7 995 biopsies taken without
disinfectant (58 hospitalisations, rate 0.73%; P = 0.33) after
the collaborative-wide antibiotic intervention (Fig. 4).
Discussion
In our present evaluation of nearly 18 000 TRUS-guided
prostate biopsies taken in Michigan, ~30% of TRUS-guided
prostate biopsies used a needle disinfectant step. Amongst
this large sample of patients from academic and community
urology practices, the rate of infection-related hospitalisation
within 30 days of biopsy was lower amongst biopsies where a
disinfectant technique was used. However, after accounting
for potential confounders, adjusted hospitalisation rates no
longer differed across study groups. A sub-group analysis of
the biopsies taken before implementation of a State-wide
antibiotic intervention showed that there was no significant
difference in hospitalisation rates during that period.
Similarly, when examining biopsies taken after the antibiotic
intervention, hospitalisation rates did not differ significantly.
Needle Disinfectant Technique No Needle Disinfectant Technique
0.90%
0.60%






Fig. 3 Comparison of the rate of infection-related hospitalisation after prostate biopsy: (A) observed rate (B) risk adjusted* rate (*adjusted for age,
presence of diabetes, history of prior biopsy, and timing of biopsy related to collaborative-wide antibiotic initiative). Chi-squared test used to compare
differences across groups.
Table 2 Results of multivariable regression analysis to predict probability
of hospitalisation after prostate biopsy.
Variable Adjusted OR (95% CI) P
Disinfectant technique used
No Reference
Yes 0.76 (0.50–1.15) 0.19
Age (per year) 0.99 (0.96–1.01) 0.18
Diabetes present
No Reference
Yes 1.87 (1.25–2.78) 0.002
History of prior biopsy
No Reference
Yes 0.94 (0.63–1.39) 0.75
Study period
Prior to antibiotic intervention Reference
After antibiotic intervention 0.61 (0.43–0.87) 0.006
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Our present findings build on a single-centre investigation
that introduced the concept of the formalin disinfectant
technique [7]. Issa et al. [7] reported a 0.30% rate of urinary
infection or sepsis in 1 642 prostate biopsies taken with a
10% formalin needle disinfection step. Despite a very low rate
of infection, the authors did not find a statistically significant
reduction in infections when disinfectant biopsies were
compared to a cohort of 990 biopsies taken in the same
centre without needle disinfection (infection rate 0.80%;
P = 0.13). To further evaluate a mechanistic explanation for a
protective effect of formalin, in vitro experimentation has also
been used to show that treating MacConkey agar dishes with
10% formalin for 10 s prevents growth of fluoroquinolone
resistant E. Coli in the culture media and further, that needle-
tips from transrectal biopsies where a needle disinfectant
technique is used do not demonstrate bacterial growth [7]. In
the present analysis, we found a lower rate of hospitalisation
when the biopsy protocol included a disinfectant step (0.60%
vs 0.90%; P = 0.04); however, given the observational nature
of our investigation it was necessary to evaluate for
alternative explanations for our findings. As noted, the
MUSIC led a State-wide antibiotic initiative associated with
notable reductions in infection rates during the period
evaluated in the present analysis [4]. Given the impact of the
antibiotic initiative on the outcome of interest, it was
important to account for this and other important co-variates
in evaluating the disinfectant technique. After accounting for
these factors, there was not a statistically significant difference
in hospitalisation attributable to the use of a disinfectant
technique.
The included sub-analyses were performed to provide more
detail on the impact of needle disinfection whilst accounting
for the collaborative-wide antibiotic intervention in a different
way. In looking at only the biopsies taken before the changes
to antibiotic prophylaxis, the absolute difference in
hospitalisation rates was larger than when looking at the
entire cohort (1.21% for biopsies that did not use disinfectant
vs 0.76% for those that did). Statistical significance may have
been precluded due to the small number of events in both
groups and the relatively limited number of biopsies (661)
taken with disinfectant before the antibiotic intervention.
After our antibiotic intervention, we found the rate of
infection-related hospitalisation dropped to 0.73% amongst
biopsies taken without a disinfectant technique. Despite a
larger cohort of disinfectant biopsies in this period, the rate
of hospitalisation (0.58%) was not significantly lower when
compared to biopsies taken without disinfectant. We
hypothesise that the impact of disinfectant may be masked in
the period after the antibiotic intervention given the
substantially lower rate of infection in the no disinfectant
group. Disinfectant techniques may have protective effects;
however, we are not able to show this in a statistically
significant manner given the relative rarity of events and the
confounding influence of our antibiotic State-wide guideline
intervention.
Before considering increased adoption or further
investigation, potential safety concerns of needle disinfection
should be considered. Formalin is an aqueous solution of
formaldehyde, recognised by the WHO and Environmental
Protection Agency (EPA) as a chemical irritant and possible
carcinogen [11,12]. The average formaldehyde exposure from
a standard 12-core biopsy using a disinfectant technique has
been estimated at 3.9 mg [7]. This is significantly lower than
the maximum exposure threshold set by the EPA at 0.2 mg/
kg/day (i.e. for a 70 kg person maximum daily exposure
threshold = 14 mg) [11]. Formaldehyde exposure is common
in normal human living environments, and the exposure
from a single prostate biopsy is in range with the degree of
Needle Disinfectant Technique No Needle Disinfectant Technique
1.21%
0.76%
After antibiotic interventionPrior to antibiotic intervention
No. of events 5
661
56 5827
4638 4660 7995No. of biopsies
0.58%
0.73%
P = 0.33P = 0.31
Fig. 4 Comparison of the observed rate of infection-related hospitalisation for biopsies performed before and after the collaborative-wide antibiotic
intervention. Chi-squared test used to compare differences across groups.
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exposure humans experience from common sources on a
daily basis (Table S1 [7,11,12]). Although, our present
investigation did not directly evaluate exposure or safety, the
published data suggests the potential for harmful effects from
a formalin disinfectant step would be remote. Incorporating a
saline rinse after formalin disinfection may further reduce the
load inoculated to the prostate, and is used as an adjunct by
some urologists in the MUSIC. Similarly, it is unlikely that
isopropyl alcohol is of substantial concern for patient safety.
Isopropyl alcohol is a common over-the-counter disinfectant
with a proven safety record when used in small volumes, and
according to the Centers for Disease Control it is not a
human carcinogen [13]. Across our collaborative there have
been no reports of biopsy complications or unintended
events, such as granulomatous prostatitis or impaired
pathological assessment, which could be linked to the use of a
disinfectant technique.
Our present findings should be considered in the setting of
several limitations. First, this is an observational analysis
where the disinfectant technique was not strictly standardised
(e.g., dwell time in disinfectant solutions was per clinician
routine and may vary across providers) and, as detailed, an
antibiotic-based quality improvement initiative was
implemented during the period evaluated. Further, it is
possible other co-variates (e.g., antibiotic type) that we are
not able to account for may influence the outcome as well.
Although, a randomised controlled trial would be beneficial
for establishing whether the disinfectant technique is
protective, it would need to be a large trial given the rarity of
infection-related hospitalisations after prostate biopsy (e.g.,
assuming a hospitalisation rate of 1.2% in the control group,
and the disinfectant technique could reduce the event rate by
0.5%, it would require nearly 6 000 patients in each group to
detect the effect of disinfectant with a power of 0.8). In the
context of limited resources, we felt an observational analysis
would be an important first-step in determining whether
further consideration of disinfectant techniques is warranted.
Second, physician self-report for disinfectant utilisation was
used to group biopsies into the study groups. The MUSIC
Coordinating Centre verified behaviour for each urologist.
Although there is possibility of mis-grouping of some of the
biopsies, we anticipate the impact of mis-grouping would be
small.
These limitations notwithstanding and in the context of
concerns about both rising antibiotic resistance and the safety
of extended fluoroquinolone therapy [14] there are important
implications to this work. Avoiding infectious hospitalisation,
the associated morbidity, and costs via a simple, low-risk
modification to biopsy procedures represents a potential for
improvement with minimal disadvantages. Furthermore, as
needle disinfection does not increase antibiotic utilisation; it
may represent an important adjunct or alternative to the
antibiotic-based quality improvement strategies that continue
to carry the potential for worsening antibiotic resistance
despite laudable reductions in post-biopsy infections shown
within our collaborative [4] and elsewhere [3]. This, to our
knowledge, represents the largest evaluation of the needle
disinfectant technique to date. In the absence of a statistically
significant difference in adjusted hospitalisation rates, we
cannot state that needle disinfection should be a new
standard, but feel it may remain prudent to incorporate
needle disinfection into biopsy regimens given the potential
for benefit with little to no risk. Further, we feel this
investigation provides evidence regarding the necessity of a
prospective study of this technique in order to limit
confounding and more definitively determine if there is a
benefit to needle disinfection.
Moving forward, we have planned further prospective
investigation of this technique within the MUSIC, where
several pilot sites have changed practice to adopt a
disinfectant technique. Analysis of outcomes before and
after this change within pilot sites will afford us further
information on the impact of needle disinfection. We are
also interested in the sub-population of biopsies being
taken with isopropyl alcohol as a disinfectant. Given
patients in this group had no infectious hospitalisations
during the study; we continue to monitor the impact of
this method to determine if it is possibly superior to the
formalin technique.
In conclusion, men undergoing TRUS-guided prostate
biopsy within the MUSIC were less commonly hospitalised
for infectious complications within 30 days of biopsy when
their procedure included a needle disinfectant technique
using either 10% formalin or 70% isopropyl alcohol.
Despite differences in hospitalisation rates, multivariable
analyses revealed no significant difference in
hospitalisation rates attributable to the use of a needle
disinfectant after accounting for potential confounders.
Despite these findings, needle disinfection may remain a
scalable, low-risk intervention to reduce infectious
complications after prostate biopsy that warrants further
investigation.
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